| 2024 |
Kamsani, S. H., & Middeldorp, M. E. (2024). Adherence in a fortnight: is this a true reflection of a lifetime?. Heart, 3 pages.
DOI |
| 2024 |
Noubiap, J. J., Nyaga, U. F., Middeldorp, M. E., Stokes, M. B., & Sanders, P. (2024). Cardiac imaging correlates and predictors of stroke in patients with atrial fibrillation: a meta-analysis. Journal of Cardiovascular Medicine, 25(4), 280-293.
DOI |
| 2024 |
Desteghe, L., & Middeldorp, M. (2024). Patient-reported outcomes in atrial fibrillation: is it worthwhile systematically evaluating?. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2 pages.
DOI |
| 2024 |
Ariyaratnam, J. P., Mishima, R. S., Kadhim, K., Emami, M., Fitzgerald, J. L., Thiyagarajah, A., . . . Elliott, A. D. (2024). Utility and Validity of the HFA-PEFF and H<inf>2</inf>FPEF Scores in Patients With Symptomatic Atrial Fibrillation. JACC: Heart Failure, S2213-1779(24)00146-X.
DOI |
| 2024 |
Lobeek, M., Middeldorp, M. E., Van Gelder, I. C., & Rienstra, M. (2024). Multimorbidity in patients with atrial fibrillation. Open Heart, 11(1), e002641.
DOI |
| 2024 |
Middeldorp, M. E., & Sandhu, R. K. (2024). The stroke enigma: decoding the sex risk factor in atrial fibrillation. European Heart Journal, 45(2), 114-116.
DOI Scopus1 WoS1 |
| 2023 |
Elliott, A. D., Benjamin, E. J., & Middeldorp, M. E. (2023). Prevention of atrial fibrillation: a call to action. European Heart Journal, 44(47), 4994-4996.
DOI Scopus1 WoS1 |
| 2023 |
Middeldorp, M. E., Sandhu, R. K., Mao, J., Gencer, B., Danik, J. S., Moorthy, V., . . . Albert, C. M. (2023). Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation: Subanalysis of the VITAL Study. Circulation: Arrhythmia and Electrophysiology, 16(12), 651-662.
DOI |
| 2023 |
Tu, S. J., Gallagher, C., Elliott, A. D., Bradbury, K. E., Marcus, G. M., Linz, D., . . . Wong, C. X. (2023). Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation. Heart, 109(22), 1683-1689.
DOI Scopus2 WoS2 |
| 2023 |
Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., Lau, D. H., . . . Elliott, A. D. (2023). Influence of Sex on Efficacy of Exercise Training for Patients with Symptomatic Atrial Fibrillation: Insights from the ACTIVE-AF Randomised Controlled Trial. European Journal of Preventive Cardiology, 30(18), 2006-2014.
DOI Scopus1 |
| 2023 |
Noubiap, J. J., Tu, S. J., Emami, M., Middeldorp, M. E., Elliott, A. D., & Sanders, P. (2023). Incident atrial fibrillation in relation to ventilatory parameters: a prospective cohort study.. Can J Cardiol, 39(5), 614-622.
DOI Scopus5 WoS1 Europe PMC2 |
| 2023 |
Middeldorp, M. E., & Sanders, P. (2023). Reply to the Editor — The promising future of remote monitoring for cardiac implantable electronic devices. Heart Rhythm O2, 4(4), 288-289.
DOI |
| 2023 |
Heath, K., O'Shea, C., Thomas, G., Harper, C., Campbell, K., Sanders, P., & Middeldorp, M. E. (2023). Impact of intensive follow-up of cardiac implantable electronic devices via remote monitoring: A pilot study. Heart Rhythm O2, 4(2), 90-96.
DOI Scopus3 WoS2 Europe PMC2 |
| 2023 |
Noubiap, J. J., Thomas, G., Kamtchum-Tatuene, J., Middeldorp, M. E., & Sanders, P. (2023). High-risk carotid plaques and incident ischemic stroke in patients with atrial fibrillation in the Cardiovascular Health Study.. Eur J Neurol, 30(7), 2042-2050.
DOI |
| 2023 |
Middeldorp, M. E., Kamsani, S. H., & Sanders, P. (2023). Obesity and atrial fibrillation: Prevalence, pathogenesis, and prognosis.. Progress in cardiovascular diseases, 78, S0033-0620(23)00040-3.
DOI Scopus6 Europe PMC2 |
| 2023 |
Verdicchio, C. V., Gallagher, C., Mahajan, R., Middeldorp, M. E., Linz, D., Lau, D. H., . . . Elliott, A. D. (2023). Use of heart rate for guiding exercise training in patients with atrial fibrillation. Journal of Sports Medicine and Physical Fitness, 63(1), 188-194.
DOI Scopus1 |
| 2023 |
van den Bruck, J. H., Middeldorp, M., Sultan, A., Scheurlen, C., Seuthe, K., Wörmann, J., . . . Lüker, J. (2023). Impact of ventricular arrhythmia management on suboptimal biventricular pacing in cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology, 66(2), 353-361.
DOI Scopus1 WoS1 Europe PMC1 |
| 2023 |
Noubiap, J. J., Thomas, G., Middeldorp, M. E., Fitzgerald, J. L., Harper, C., & Sanders, P. (2023). Atrial fibrillation detection using insertable cardiac monitor after stroke: a real-word cohort study. Journal of Cardiovascular Electrophysiology, 34(1), 142-146.
DOI Scopus3 WoS3 Europe PMC2 |
| 2023 |
Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M., & Sanders, P. (2023). Epidemiology and modifiable risk factors for atrial fibrillation. Nature Reviews Cardiology, 20(6), 404-417.
DOI Scopus51 WoS11 Europe PMC22 |
| 2023 |
Noubiap, J. J., & Middeldorp, M. E. (2023). Prevention of cardiac conduction disease: a long way to go. European Heart Journal, 44(12), 1067-1069.
DOI Scopus1 WoS1 |
| 2023 |
Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M., & Sanders, P. (2023). Author Correction: Epidemiology and modifiable risk factors for atrial fibrillation.. Nat Rev Cardiol, 20(6), 429.
DOI |
| 2023 |
Elliott, A. D., Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., . . . Sanders, P. (2023). An Exercise and Physical Activity Program in Patients With Atrial Fibrillation. JACC: Clinical Electrophysiology, 9(4), 455-465.
DOI Scopus14 WoS6 Europe PMC4 |
| 2023 |
O'Shea, C. J., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J. M., Russo, A. M., . . . Sanders, P. (2023). Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.. J Interv Card Electrophysiol, 66(7), 1659-1668.
DOI Scopus2 WoS1 Europe PMC2 |
| 2022 |
Middeldorp, M. E., Lyrtzis, E., Health, K., Hall, T., Kadhim, K., & Sanders, P. (2022). Assessment of available online educational resources for patients with atrial fibrillation. Heart Rhythm O2, 4(3), 187-192.
DOI Scopus3 Europe PMC2 |
| 2022 |
Sanders, P., Kamsani, S. H., & Middeldorp, M. E. (2022). Primum Non Nocere: Serial Screening for AF, Who, How, and Why?. JACC: Clinical Electrophysiology, 8(12), 1535-1538.
DOI |
| 2022 |
Hendriks, J. M., Elliott, A. D., Middeldorp, M. E., & Sanders, P. (2022). Contributing factors to personalised medicine in atrial fibrillation.. Heart, 109(3), 164-165.
DOI Scopus1 WoS1 |
| 2022 |
Middeldorp, M. E., Ariyaratnam, J. P., Kamsani, S. H., Albert, C. M., & Sanders, P. (2022). Hypertension and atrial fibrillation.. Journal of hypertension, 40(12), 2337-2352.
DOI Scopus1 WoS2 Europe PMC1 |
| 2022 |
Middeldorp, M. E., & Albert, C. M. (2022). Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery. European Heart Journal, 43(31), 2981-2983.
DOI Scopus1 WoS1 |
| 2022 |
Walfridsson, U., Walfridsson, H., Middeldorp, M. E., Sanders, P., & Årestedt, K. (2022). Validation of the English version of the arrhythmia-specific questionnaire in tachycardia and arrhythmia (ASTA): a Rasch evaluation study.. Journal of patient-reported outcomes, 6(1), 12 pages.
DOI |
| 2022 |
Thiyagarajah, A., Mahajan, R., Iwai, S., Gupta, A., Linz, D., Chim, I., . . . Sanders, P. (2022). Single Ring Isolation For Atrial Fibrillation Ablation: Impact of the Learning Curve.. Journal of cardiovascular electrophysiology, 33(4), 608-617.
DOI Scopus2 WoS1 Europe PMC2 |
| 2022 |
Malik, V., Elliott, A. D., Thomas, G., Mishima, R. S., Pitman, B., Middeldorp, M. E., . . . Sanders, P. (2022). Autonomic Afferent Dysregulation in Atrial Fibrillation. JACC: Clinical Electrophysiology, 8(2), 152-164.
DOI Scopus10 WoS3 Europe PMC6 |
| 2022 |
Noubiap, J. J., Thomas, G., Nyaga, U. F., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2022). Sex disparities in enrolment and reporting of outcomes by sex in contemporary clinical trials of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 33(5), 845-854.
DOI Scopus5 WoS1 Europe PMC5 |
| 2022 |
Noubiap, J. J., Middeldorp, M. E., Thomas, G., & Sanders, P. (2022). CHA₂DS₂-VASc score is no longer enough-Authors' reply. Europace, 24(7), 1195.
DOI |
| 2022 |
Fitzgerald, J. L., Middeldorp, M. E., Gallagher, C., & Sanders, P. (2022). Lifestyle Modification and Atrial Fibrillation: Critical Care for Successful Ablation.. Journal of Clinical Medicine, 11(9), 2660-1-2660-17.
DOI Scopus8 WoS6 Europe PMC5 |
| 2022 |
Noubiap, J. J., Nyaga, U. F., Middeldorp, M. E., Fitzgerald, J. L., Ariyaratnam, J. P., Thomas, G., & Sanders, P. (2022). Frequency and prognostic significance of atrial fibrillation in acute pulmonary embolism: A pooled analysis. Respiratory Medicine, 199, 1-7.
DOI Scopus2 WoS2 |
| 2022 |
Noubiap Nzeale, J. J., Thomas, G., Agbaedeng, T. A., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2022). Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States. European Heart Journal - Quality of Care and Clinical Outcomes, 8(8), 852-860.
DOI Scopus3 WoS3 Europe PMC2 |
| 2021 |
Middeldorp, M. E., Lyrtzis, E., Heath, K. M., Hall, T., Kadhim, K., & Sanders, P. (2021). Assessment of available online educational resources for patients with atrial fibrillation (Preprint).
DOI |
| 2021 |
Iacopo, F., Branch, M., Cardinale, D., Middeldorp, M., Sanders, P., Cohen, J. B., . . . Brown, S. A. (2021). Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors. Current Treatment Options in Cardiovascular Medicine, 23(1), 1-23.
DOI Scopus8 WoS2 |
| 2021 |
Elliott, A. D., Verdicchio, C. V., Gallagher, C., Linz, D., Mahajan, R., Mishima, R., . . . Sanders, P. (2021). Factors contributing to exercise intolerance in patients with atrial fibrillation. Heart, Lung and Circulation, 30(7), 947-954.
DOI Scopus10 WoS7 Europe PMC6 |
| 2021 |
O’Shea, C. J., Thomas, G., Middeldorp, M. E., Harper, C., Elliott, A. D., Ray, N., . . . Sanders, P. (2021). Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic. European Heart Journal, 42(5), 520-528.
DOI Scopus47 WoS39 Europe PMC30 |
| 2021 |
Mishima, R. S., Verdicchio, C. V., Noubiap, J. J., Ariyaratnam, J. P., Gallagher, C., Jones, D., . . . Elliott, A. D. (2021). Self-reported Physical Activity and Atrial Fibrillation Risk: A Systematic Review and Meta-analysis. Heart Rhythm, 18(4), 520-528.
DOI Scopus18 WoS12 Europe PMC9 |
| 2021 |
Hendriks, J. M., Gallagher, C., Middeldorp, M. E., Lau, D. H., & Sanders, P. (2021). Risk factor management and atrial fibrillation.. Europace, 23(Supplement_2), ii52-ii60.
DOI Scopus19 WoS17 Europe PMC9 |
| 2021 |
Thiyagarajah, A., Mahajan, R., Iwai, S., Griffin, A., S. Mishima, R., Linz, D., . . . Sanders, P. (2021). Single ring isolation with Inferior line sparing for atrial fibrillation. Circulation: Arrhythmia and Electrophysiology, 14(4), 452-454.
DOI Scopus3 WoS2 Europe PMC1 |
| 2021 |
Noubiap, J. J., Agbaedeng, T. A., Kamtchum-Tatuene, J., Fitzgerald, J. L., Middeldorp, M. E., Kleinig, T., & Sanders, P. (2021). Rhythm monitoring strategies for atrial fibrillation detection in patients with cryptogenic stroke: A systematic review and meta-analysis. IJC Heart and Vasculature, 34, 1-8.
DOI Scopus24 WoS19 Europe PMC13 |
| 2021 |
O’Shea, C. J., Middeldorp, M. E., Thomas, G., Harper, C., Elliott, A. D., Ray, N., . . . Sanders, P. (2021). Atrial fibrillation burden during the coronavirus disease 2019 pandemic. EP Europace, 23(9), 1493-1501.
DOI Scopus19 WoS16 Europe PMC14 |
| 2021 |
Gallagher, C., Fitzgerald, J. L., Stokes, M. B., Noubiap, J. J., Elliott, A. D., Hendriks, J. M., . . . Lau, D. H. (2021). Risk Factor Management in Atrial Fibrillation: How to Deliver a Successful Clinic. Current Cardiovascular Risk Reports, 15(7), 9 pages.
DOI Scopus3 WoS3 |
| 2021 |
Noubiap, J. J., Feteh, V. F., Middeldorp, M. E., Fitzgerald, J. L., Thomas, G., Kleinig, T., . . . Sanders, P. (2021). A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation. EP-Europace, 23(10), 1528-1538.
DOI Scopus15 WoS12 Europe PMC7 |
| 2021 |
O'Shea, C. J., Middeldorp, M. E., Campbell, K., & Sanders, P. (2021). Cardiac defibrillator therapies during the COVID-19 pandemic: how you look provides perspective. European Heart Journal, 43(11), ehab385-1-ehab385-2.
DOI Scopus2 WoS2 |
| 2021 |
Noubiap, J. J., Fitzgerald, J. L., Gallagher, C., Thomas, G., Middeldorp, M. E., & Sanders, P. (2021). Rates, predictors, and impact of smoking cessation after stroke or transient ischemic attack: a systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 30(10), 106012-1-106012-10.
DOI Scopus16 WoS12 Europe PMC10 |
| 2021 |
Elliott, A. D., Middeldorp, M. E., & Linz, D. K. (2021). The ins and outs of physical activity monitoring: implications for atrial fibrillation management.. Eur Heart J, 42(38), 3989-3991.
DOI Scopus5 WoS3 Europe PMC1 |
| 2021 |
Kadhim, K., Middeldorp, M. E., Elliott, A. D., Agbaedeng, T., Gallagher, C., Malik, V., . . . Sanders, P. (2021). Prevalence and assessment of sleep-disordered breathing in patients with atrial fibrillation: a systematic review and meta-analysis. Canadian Journal of Cardiology, 37(11), 1846-1856.
DOI Scopus19 WoS15 Europe PMC10 |
| 2021 |
O'Shea, C. J., Middeldorp, M., Hendriks, J. M., Brooks, A. G., Harper, C., Thomas, G., . . . Sanders, P. (2021). Remote monitoring of implantable loop recorders: false-positive alert episode burden. Circulation: Arrhythmia and Electrophysiology, 14(11), 1048-1050.
DOI Scopus23 WoS14 Europe PMC11 |
| 2021 |
Emami, M., Agbaedeng, T. A., Thomas, G., Middeldorp, M. E., Thiyagarajah, A., Wong, C. X., . . . Sanders, P. (2021). Accelerated biological aging secondary to cardiometabolic risk factors is a predictor of cardiovascular mortality: a systematic review and meta-analysis. Canadian Journal of Cardiology, 38(3), 365-375.
DOI Scopus9 WoS2 Europe PMC6 |
| 2021 |
Middeldorp, M. E., Gupta, A., Elliott, A., Kadhim, K., Thiyagarajah, A., Gallagher, C., . . . Sanders, P. (2021). Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart (British Cardiac Society), 107(12), 971-976.
DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2021). Risk factor management in atrial fibrillation : A key pillar of care. Medicine Today, 22(9), 42-49. |
| 2021 |
Thiele, H., Osto, E., Lionetti, V., Stellos, K., Madonna, R., Kraler, S., & Middeldorp, M. (2021). Welcome on board! Meet the new EHJ board reviewers. EUROPEAN HEART JOURNAL, 43(1), 9-11.
DOI |
| 2021 |
Gallagher, C., Middeldorp, M. E., Hendriks, J. M., Lau, D. H., & Sanders, P. (2021). Lifestyle as a Risk Factor for Atrial Fibrillation.. Card Electrophysiol Clin, 13(1), 263-272.
DOI Scopus5 Europe PMC2 |
| 2020 |
Rocheleau, S., Gallagher, C., Pitman, B. M., Tu, S. J., Hanna-Rivero, N., Clarke, N., . . . Wong, C. X. (2020). Predictors of anticoagulation use in indigenous and non-indigenous Australians with atrial fibrillation. Heart Lung and Circulation, 30(5), 707-713.
DOI |
| 2020 |
Noubiap, J. J., Agbaedeng, T. A., Tochie, J. N., Nkeck, J. R., Ndoadoumgue, A. L., Fitzgerald, J. L., . . . Sanders, P. (2020). Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa. The American Journal of Cardiology, 138, 72-79.
DOI Scopus11 WoS10 Europe PMC4 |
| 2020 |
Gallagher, C., Nyfort-Hansen, K., Rowett, D., Wong, C. X., Middeldorp, M. E., Mahajan, R., . . . Hendriks, J. M. (2020). Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis. Open Heart, 7(1), 9 pages.
DOI Scopus32 WoS26 Europe PMC14 |
| 2020 |
Ariyaratnam, J. P., Middeldorp, M., Thomas, G., Noubiap Nzeale, J. J. N., Lau, D., & Sanders, P. (2020). Risk factor management before and after atrial fibrillation ablation. Cardiac Electrophysiology Clinics, 12(2), 141-154.
DOI Scopus5 Europe PMC4 |
| 2020 |
Middeldorp, M. E., Elliott, A. D., Gallagher, C., Linz, D., Hendriks, J. M. L., Mahajan, R., . . . Sanders, P. (2020). Late-onset thyrotoxicosis after the cessation of amiodarone. Indian Pacing and Electrophysiology Journal, 20(6), 265-268.
DOI Scopus1 Europe PMC2 |
| 2020 |
Heath, K. M., Lyrtzis, E., Middeldorp, M. E., Sanders, P., & Lau, D. H. (2020). False remote monitoring alerts from explanted cardiac implantable electronic device: How is this possible?. Journal of Electrocardiology, 62, 132-133.
DOI |
| 2020 |
Middeldorp, M. E., Ariyaratnam, J., Lau, D., & Sanders, P. (2020). Lifestyle modifications for treatment of atrial fibrillation. Heart, 106(5), 325-332.
DOI Scopus75 WoS50 Europe PMC38 |
| 2020 |
Elliott, A. D., Linz, D., Mishima, R., Kadhim, K., Gallagher, C., Middeldorp, M. E., . . . Sanders, P. (2020). Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort. European Heart Journal, 41(15), 1479-1486.
DOI Scopus91 WoS75 Europe PMC43 |
| 2020 |
O'shea, C. J., Middeldorp, M. E., Hendriks, J. M., Brooks, A. G., Lau, D. H., Emami, M., . . . Sanders, P. (2020). Remote monitoring alert burden: an analysis of transmission in >26,000 patients. JACC: Clinical Electrophysiology, 7(2), 226-234.
DOI Scopus38 WoS26 Europe PMC20 |
| 2020 |
Gallagher, C., Wong, C. X., Hendriks, J. M., Nyfort-Hansen, K., Rowett, D., Bednarz, J., . . . Sanders, P. (2020). Opportunities to reduce the risk of stroke in AF: the REVIEW AF study. European Heart Journal, 41(Supplement_2), 3427.
DOI |
| 2019 |
Nguyen, M. T., Gallagher, C., Pitman, B. M., Emami, M., Kadhim, K., Hendriks, J. M., . . . Wong, C. X. (2019). Quality of warfarin anticoagulation in indigenous and non-indigenous Australians with atrial fibrillation. Heart, Lung and Circulation, 29(8), 1122-1128.
DOI Scopus4 WoS4 Europe PMC2 |
| 2019 |
Pluymaekers, N. A. H. A., Hermans, A. N. L., Middeldorp, M. E., Kadhim, K., Crijns, H. J. G. M., Sanders, P., & Linz, D. (2019). Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management. IJC Heart and Vasculature, 25, 3 pages.
DOI Scopus4 WoS3 Europe PMC3 |
| 2019 |
Gallagher, C., Middeldorp, M. E., & Sanders, P. (2019). Weight and risk of incident atrial fibrillation—body mass index variability or body mass gain?. Mayo Clinic Proceedings, 94(2), 186-188.
DOI Scopus1 WoS1 Europe PMC1 |
| 2019 |
Middeldorp, M. E., Pathak, R. K., Lau, D. H., & Sanders, P. (2019). Prevention and regressive effect of weight-loss and risk factor modification on atrial fibrillation: the reverse-AF study - authors' reply. Europace, 21(6), 990-991.
DOI Scopus5 WoS4 Europe PMC2 |
| 2019 |
Linz, D., Brooks, A. G., Elliott, A. D., Nalliah, C. J., Hendriks, J. M. L., Middeldorp, M. E., . . . Sanders, P. (2019). Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study. JACC: Clinical Electrophysiology, 5(6), 692-701.
DOI Scopus81 WoS61 Europe PMC30 |
| 2019 |
Hendriks, J. M., Brooks, A. G., Rowett, D., Moss, J. R., Gallagher, C., Nyfort-Hansen, K., . . . Sanders, P. (2019). Home-based education and learning program for atrial fibrillation: rationale and design of the HELP-AF study. Canadian Journal of Cardiology, 35(7), 846-854.
DOI Scopus14 WoS13 Europe PMC4 |
| 2019 |
Middeldorp, M. E., Wong, C. X., Gallagher, C., Elliott, A. D., Lau, D. H., & Sanders, P. (2019). No time to weight: obesity through life and AF risk. European Heart Journal, 40(34), 2867-2869.
DOI Scopus2 WoS2 Europe PMC1 |
| 2019 |
Kadhim, K., Middeldorp, M. E., Hendriks, J. M., Lau, D. H., & Sanders, P. (2019). Bariatric surgery and atrial fibrillation: does the end justify the means?. EP Europace, 21(10), 1454-1456.
DOI Scopus3 WoS2 |
| 2019 |
Gallagher, C., Hendriks, J. M., Middeldorp, M. E., Elliott, A. D., Lau, D. H., & Sanders, P. (2019). Reducing the burden of atrial fibrillation cost: is integrated care the answer?. Canadian Journal of Cardiology, 35(9), 1094-1096.
DOI Scopus5 WoS4 |
| 2019 |
Malik, V., Lau, D. H., Linz, D., Middeldorp, M. E., & Sanders, P. (2019). Is the stomach a way to one's heart? Gastric autonomic activity and AF susceptibility in gastro-esophageal reflux disease. Journal of Cardiovascular Electrophysiology, 30(11), 2271-2273.
DOI |
| 2019 |
Kadhim, K., Middeldorp, M. E., Elliott, A. D., Jones, D., Hendriks, J. M. L., Gallagher, C., . . . Linz, D. (2019). Self-reported daytime sleepiness and sleep-disordered breathing in patients with atrial fibrillation: SNOozE-AF. The Canadian Journal of Cardiology, 35(11), 1457-1464.
DOI Scopus50 WoS40 Europe PMC26 |
| 2019 |
Gallagher, C., Rowett, D., Nyfort-Hansen, K., Simmons, S., Brooks, A. G., Moss, J. R., . . . Sanders, P. (2019). Patient-centered educational resources for atrial fibrillation. JACC: Clinical Electrophysiology, 5(10), 1101-1114.
DOI Scopus16 WoS11 Europe PMC4 |
| 2019 |
Middeldorp, M. E., Lau, D. H., & Sanders, P. (2019). Is bypassing traditional weight-loss the answer for atrial fibrillation?. Circulation: Arrhythmia and Electrophysiology, 12(10), 3 pages.
DOI Scopus2 WoS3 |
| 2019 |
Elliott, A. D., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2019). Drinking to atrial fibrillation: alcohol and atrial fibrillation incidence. EP-Europace, 22(2), 177-178.
DOI |
| 2019 |
Gallagher, C., Hendriks, J. M. L., Giles, L., Karnon, J., Pham, C., Elliott, A. D., . . . Wong, C. X. (2019). Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart, 105(17), 1358-1363.
DOI Scopus50 WoS38 Europe PMC17 |
| 2019 |
Rangnekar, G., Gallagher, C., Wong, G. R., Rocheleau, S., Brooks, A. G., Hendriks, J. M. L., . . . Lau, D. H. (2019). Oral anticoagulation therapy in atrial fibrillation patients managed in the emergency department compared to cardiology outpatient: opportunities for improved outcomes. Heart Lung and Circulation, 28(4), 43-46.
DOI Scopus6 WoS5 Europe PMC2 |
| 2018 |
Middeldorp, M., Pathak, R., Meredith, M., Mehta, A., Elliott, A., Mahajan, R., . . . Sanders, P. (2018). PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. Europace, 20(12), 1929-1935.
DOI Scopus235 WoS197 Europe PMC98 |
| 2018 |
Hendriks, J. M., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2018). New approaches to detection of atrial fibrillation. Heart, 104(23), 1898-1899.
DOI Scopus4 WoS3 Europe PMC2 |
| 2018 |
Linz, D., Kadhim, K., Brooks, A. G., Elliott, A. D., Hendriks, J. M. L., Lau, D. H., . . . Sanders, P. (2018). Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients. International Journal of Cardiology, 272, 155-161.
DOI Scopus34 WoS30 Europe PMC16 |
| 2018 |
Munawar, D., Mahajan, R., Linz, D., Wong, G., Khokhar, K., Thiyagarajah, A., . . . Lau, D. (2018). Predicted longevity of contemporary cardiac implantable electronic devices: a call for industry-wide “standardized” reporting. Heart Rhythm, 15(12), 1756-1763.
DOI Scopus27 WoS21 Europe PMC10 |
| 2018 |
Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S., Munwar, D. A., . . . Sanders, P. (2018). Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. European Heart Journal, 39(16), 1407-1415.
DOI Scopus188 WoS158 Europe PMC76 |
| 2018 |
Elliott, A. D., Mahajan, R., Linz, D., Stokes, M., Verdicchio, C. V., Middeldorp, M. E., . . . Sanders, P. (2018). Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation. Clinical Cardiology, 41(6), 843-848.
DOI Scopus35 WoS29 Europe PMC20 |
| 2018 |
Mahajan, R., Nelson, A., Pathak, R. K., Middeldorp, M. E., Wong, C. X., Twomey, D. J., . . . Sanders, P. (2018). Electroanatomical remodeling of the atria in obesity: impact of adjacent epicardial fat. JACC: Clinical Electrophysiology, 4(12), 1529-1540.
DOI Scopus106 WoS87 Europe PMC58 |
| 2017 |
Middeldorp, M., Mahajan, R., Elliott, A., Pathak, R., Twomey, D., Wilson, L., . . . Sanders, P. (2017). Premature Trigger of ERI in Medtronic EnRhythm Devices. PACE - Pacing and Clinical Electrophysiology, 40(6), 624-628.
DOI Scopus1 WoS1 Europe PMC1 |
| 2017 |
Pathak, R., Evans, M., Middeldorp, M., Mahajan, R., Mehta, A., Meredith, M., . . . Sanders, P. (2017). Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation: the CENT study. JACC: Clinical Electrophysiology, 3(5), 436-447.
DOI Scopus67 Europe PMC30 |
| 2017 |
Gallagher, C., Elliott, A., Wong, C., Rangnekar, G., Middeldorp, M., Mahajan, R., . . . Hendriks, J. (2017). Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart, 103(24), 1947-1953.
DOI Scopus150 WoS115 Europe PMC53 |
| 2017 |
Gallagher, C., Hendriks, J., Elliott, A., Wong, C., Rangnekar, G., Middeldorp, M., . . . Sanders, P. (2017). Alcohol and incident atrial fibrillation – a systematic review and meta-analysis. International Journal of Cardiology, 246, 46-52.
DOI Scopus110 WoS84 Europe PMC40 |
| 2016 |
Lim, H. S., Denis, A., Middeldorp, M. E., Lau, D. H., Mahajan, R., Derval, N., . . . Haïssaguerre, M. (2016). Persistent atrial fibrillation from the onset: a specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome. JACC: Clinical Electrophysiology, 2(2), 129-139.
DOI Scopus17 Europe PMC4 |
| 2016 |
Gallagher, C., Hendriks, J., Mahajan, R., Middeldorp, M., Elliott, A., Pathak, R., . . . Lau, D. (2016). Lifestyle management to prevent and treat atrial fibrillation. Expert Review of Cardiovascular Therapy, 14(7), 799-809.
DOI Scopus24 WoS19 Europe PMC12 |
| 2016 |
Lau, D., Middeldorp, M., & Sanders, P. (2016). Obesity paradox in atrial fibrillation: a distracting reality or fictitious finding?. European Heart Journal, 37(38), 2879-2881.
DOI Scopus13 WoS12 Europe PMC5 |
| 2016 |
Wong, G., Lau, D., Middeldorp, M., Harrington, J., Stolcman, S., Wilson, L., . . . Sanders, P. (2016). Feasibility and safety of Reveal LINQ insertion in a sterile procedure room versus electrophysiology laboratory. International Journal of Cardiology, 223, 13-17.
DOI Scopus20 WoS16 Europe PMC16 |
| 2016 |
Wong, G. R., Munawar, D. A., Twomey, D. J., Kumar, S., Middeldorp, M. E., Chapman, D., . . . Lau, D. H. (2016). Projected longevity of contemporary cardiac pacemakers: differences and impact of advanced pacing features. EUROPEAN HEART JOURNAL, 37, 1301-1302. |
| 2015 |
Wong, G. R., Lau, D. H., Baillie, T. J., Middeldorp, M. E., Steele, P. M., & Sanders, P. (2015). Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'. International Journal of Cardiology, 181, 55-56.
DOI Scopus6 WoS6 Europe PMC4 |
| 2015 |
Pathak, R., Middeldorp, M., Meredith, M., Mehta, A., Mahajan, R., Wong, C., . . . Sanders, P. (2015). Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). Journal of the American College of Cardiology, 65(20), 2159-2169.
DOI Scopus672 WoS516 Europe PMC354 |
| 2015 |
Pathak, R., Elliott, A., Middeldorp, M., Meredith, M., Mehta, A., Mahajan, R., . . . Sanders, P. (2015). Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT Study. Journal of the American College of Cardiology, 66(9), 985-996.
DOI Scopus381 WoS320 Europe PMC189 |
| 2015 |
Wong, C., Sullivan, T., Sun, M., Mahajan, R., Pathak, R., Middeldorp, M., . . . Sanders, P. (2015). Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: Clinical Electrophysiology, 1(3), 139-152.
DOI Scopus198 Europe PMC79 |
| 2014 |
Pathak, R., Middeldorp, M., Lau, D., Mehta, A., Mahajan, R., Twomey, D., . . . Sanders, P. (2014). Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF Cohort Study. Journal of the American College of Cardiology, 64(21), 2222-2231.
DOI Scopus668 WoS510 Europe PMC364 |
| 2013 |
Abed, H., Wittert, G., Leong, D., Shirazi, M., Bahrami, B., Middeldorp, M., . . . Sanders, P. (2013). Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation a randomized clinical trial. Jama-journal of the American Medical Association, 310(19), 2050-2060.
DOI Scopus545 WoS523 Europe PMC326 |
| 2013 |
Lau, D., Middeldorp, M., Brooks, A., Ganesan, A., Roberts-Thomson, K., Stiles, M., . . . Sanders, P. (2013). Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrence. PLoS One, 8(10), 1-9.
DOI Scopus47 WoS38 Europe PMC25 |
| 2013 |
Nayyar, S., Middeldorp, M., Roberts-Thomson, K., & Sanders, P. (2013). Clatter on the electrocardiogram. Journal of Electrocardiology, 46(1), 66-68.
DOI |
| 2012 |
Brooks, A., Rangnekar, G., Ganesan, A., Salna, I., Middeldorp, M., Kuklik, P., . . . Sanders, P. (2012). Characteristics of ectopic triggers associated with paroxysmal and persistent atrial fibrillation: evidence for a changing role. Heart Rhythm, 9(9), 1367-1374.
DOI Scopus13 WoS12 Europe PMC7 |
| 2011 |
Wong, C., Abed, H., Molaee, P., Nelson, A., Brooks, A., Sharma, G., . . . Sanders, P. (2011). Pericardial fat is associated with atrial fibrillation severity and ablation outcome. Journal of the American College of Cardiology, 57(17), 1745-1751.
DOI Scopus347 WoS295 Europe PMC191 |
| 2011 |
Lau, D. H., Middeldorp, M. E., Brooks, A. G., Stiles, M. K., Leong, D. P., Ganesan, A. N., . . . Sanders, P. (2011). Aortic stiffness is associated with atrial fibrillation recurrence following ablation in lone atrial fibrillation patients. EUROPEAN HEART JOURNAL, 32, 621. |
